The U.S. Food and Drug Administration (FDA) has announced a nationwide recall of one lot of Thyroid Tablets, USP 30 mg distributed by Vitruvias Therapeutics, Inc. The recall was issued after testing found that the tablets may be superpotent, meaning they could contain more thyroid hormone than intended.



